Hormone therapy for prostate cancer does not appear to increase cardiac deaths
whom the role of GnRH agonists is not as well defined and treatment decisions need to carefully weigh potential risks and benefits. Efstathiou is an instructor in Radiation Oncology at Harvard Medical School.
whom the role of GnRH agonists is not as well defined, and treatment decisions need to carefully weigh potential risks and benefits." Efstathiou is an instructor in Radiation Oncology at Harvard Medical School.